On the other hand, genetic researchers have continuously investigated and identified some candidate molecular markers (methylation of microRNA-34b/c and -124a3 or somatic mutation of ARID1A and MAGI1) for prediction of the development of metachronous GC [41,42,43]. Here, ARID1A is linked to gastric cancer.